Moderna Inc. (MRNA): Price and Financial Metrics
MRNA Price/Volume Stats
| Current price | $39.39 | 52-week high | $170.47 |
| Prev. close | $39.56 | 52-week low | $35.80 |
| Day low | $39.12 | Volume | 35,482,900 |
| Day high | $40.83 | Avg. volume | 5,143,966 |
| 50-day MA | $46.73 | Dividend yield | N/A |
| 200-day MA | $91.31 | Market Cap | 15.16B |
MRNA Stock Price Chart Interactive Chart >
Moderna Inc. (MRNA) Company Bio
Moderna, Inc. (/məˈdɜːrnə/ mə-DUR-nə) is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to produce an immune response. (Source:Wikipedia)
MRNA Price Returns
| 1-mo | 2.98% |
| 3-mo | -40.04% |
| 6-mo | -71.25% |
| 1-year | -58.49% |
| 3-year | -84.33% |
| 5-year | 99.95% |
| YTD | -60.39% |
| 2023 | -44.63% |
| 2022 | -29.28% |
| 2021 | 143.11% |
| 2020 | 434.10% |
| 2019 | 28.09% |
Loading social stream, please wait...